comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-03 01:05:04 - browse：6657

Brain cancer — Michelle Monje/Stanford University/NIH

Tocagen (TOCA) said Tuesday that a Phase 3 clinical trial involving a novel gene therapy for aggressive brain tumors will continue to a final analysis later this year, following an interim look at patient survival data conducted by independent monitors. Tocagen’s stock price dropped sharply.

The San Diego-based biotech pitched the study’s continuation as an encouraging sign for its gene therapy called Toca 511/Toca FC, which is designed to deliver a localized chemotherapy directly to the site of brain tumors.

“We believe the longer-term follow-up of patients in the final analysis, particularly for those randomized in the second enrollment period, will be important in assessing both primary and secondary endpoints,” said Tocagen CEO Marty Duvall, in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： PhRMA lawsuit over Medicare drug price negotiation tossed

WSS

What should King Charles tell the public about his cancer?

The strange history of BMI, the body mass index

GOP inquiry over gain

Supreme Court strikes down Biden student loan forgiveness program

Industry veterans launch new biotech VC with $310M

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

entertainment

comprehensive

entertainment

United colonoscopy coverage change 'may cost lives,' doctors say

Medicare Advantage proposed rates disappoint insurers

Activists slam private health insurers over coverage restrictions

The dental labor crisis is a moment of opportunity

Medical records are filled with copy

Key House Republican on health care plans exit from Congress

Medical leaders decry Supreme Court decision on affirmative action

Industry veterans launch new biotech VC with $310M

How one medical school became remarkably diverse

Why did Pfizer dish out millions for a Super Bowl ad?

explore

Industry veterans launch new biotech VC with $310M

Ukrainian soldiers say they owe lives to US

For Medicare Advantage, Democrats want stronger protections around AI

To avoid data mishandling cases, universities eye AI and other tools

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

What should King Charles tell the public about his cancer?

hotspot

hotspot

leisure time

hotspot